Catalyst Crew Technologies Announces Strategic Transition to AI-Enabled Healthcare and Planned Name Change to LataMed AI Corp.
MWN-AI** Summary
Catalyst Crew Technologies Corp. (OTC: CCTC) announced a significant shift in its business strategy, transitioning to an AI-enabled healthcare technology company. This change, disclosed in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission, emphasizes a focus on developing healthcare solutions primarily for Latin America and other emerging markets. Key areas of development include AI-driven healthcare software, telehealth platforms, remote patient monitoring, clinical data analytics, and healthcare workflow automation.
Alongside this strategic shift, Catalyst Crew Technologies plans to change its corporate name to LataMed AI Corp. and update its ticker symbol. The name change will be executed through Articles of Amendment with the State of Nevada and will require necessary approvals from the Financial Industry Regulatory Authority (FINRA). The company aims to clarify its new identity and operational focus, fostering a cohesive brand around its expansion into AI-driven healthcare technologies.
While the transition indicates a progressive move toward modernizing healthcare delivery, the company remains in its development stage. There is no assurance that it will successfully implement its new business strategy, secure financing, or generate revenues. Stakeholders have been invited to review the updates filed with the SEC for a comprehensive understanding of the company's future plans.
Catalyst Crew Technologies is committed to meeting its reporting obligations under the Securities Exchange Act of 1934 and is developing a new corporate website that reflects its updated business direction. Despite the optimistic outlook, investors are cautioned to consider the inherent risks associated with this developmental phase and the uncertainties surrounding regulatory approvals and market conditions.
MWN-AI** Analysis
Catalyst Crew Technologies Corp. (OTC: CCTC) is undergoing a significant transformation as it pivots towards AI-enabled healthcare solutions, planning to rebrand as LataMed AI Corp. This strategic shift positions the company to tap into the burgeoning health tech market, especially in Latin America and emerging markets.
Investors should approach this transition with cautious optimism. The focus on developing AI-driven healthcare software, telehealth solutions, and data analytics can serve as a major differentiator in a segment increasingly defined by technological integration. The specific markets identified by Catalyst Crew—telehealth, remote patient monitoring, and clinical data interoperability—reflect a growing demand for modern healthcare solutions, especially in regions where traditional healthcare infrastructure is limited.
However, it's worth noting that the company remains in the development stage. This means the path to revenue generation is uncertain, entailing risks associated with securing financing, partnerships, and regulatory approvals. Past performance does not guarantee future results, and the company has not generated any revenue from its new strategy, a factor that potential investors must weigh carefully.
The planned name and ticker symbol change is significant in that it signifies a clear departure from its previous identity and could help attract new investment and market attention. Investors should monitor the completion of these changes closely, understanding that the differences in identity may impact market perception and share performance.
In summation, while CCTC's strategic move towards AI-facilitated healthcare presents exciting avenues for growth, the execution of this vision remains contingent on numerous factors. Investors should perform thorough due diligence, assess risk factors mentioned in SEC filings, and remain alert to developments as the company transitions into this new, potentially lucrative phase of operations.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
CARACAS, VENEZUELA - March 4, 2026 (NEWMEDIAWIRE) - Catalyst Crew Technologies Corp. (OTC: CCTC) (the “Company”) today announced that it has filed a Current Report on Form 8-K with the U.S. Securities and Exchange Commission (“SEC”) disclosing a material change in its business direction and corporate strategy.
A copy of the Company’s Form 8-K is available for review on the SEC’s EDGAR database at:
https://www.sec.gov/Archives/edgar/data/1840439/000119312526068375/d95198d8k.htm
Investors and interested parties are encouraged to read the Form 8-K in its entirety.
Strategic Transition to AI-Enabled Healthcare Technology
As disclosed in the Form 8-K, the Company has transitioned from its prior business focus and intends to pursue operations as a development-stage artificial intelligence-enabled healthcare technology company, with an initial focus on Latin America and other emerging markets.
The Company’s anticipated areas of focus include:
- Development of AI-driven healthcare software platforms
- Telehealth and remote patient monitoring technologies
- Clinical data analytics and interoperability systems
- Healthcare workflow and administrative automation solutions
- Strategic acquisitions and partnerships within the healthcare technology sector
The Company remains in the development stage of this strategic transition and is actively implementing its new plan of operations. There can be no assurance that the Company will successfully implement its new business plan, secure financing, complete acquisitions, enter into definitive agreements, or generate revenues.
Planned Corporate Name Change and Ticker Symbol Change
In connection with its revised strategic direction, the Company intends to change its corporate name to LataMed AI Corp.
The proposed name change is expected to be effected through the filing of Articles of Amendment with the State of Nevada and is subject to required corporate approvals.
In addition, the Company intends to submit a Company Related Action Notification Form and supporting documentation to the Financial Industry Regulatory Authority (“FINRA”), pursuant to Rule 6490 and related FINRA procedures, requesting review and processing of both the corporate name change and a corresponding ticker symbol change.
The filing of Articles of Amendment and submission to FINRA are procedural steps in the corporate action process. Neither the corporate name change for marketplace purposes nor any ticker symbol change will become effective until FINRA has completed its review and announces the effective date of the corporate action.
There can be no assurance regarding the timing of FINRA’s review or that FINRA will approve the requested corporate action. The Company will issue a subsequent press release upon confirmation of the effective date assigned by FINRA.
Reporting and Corporate Communications
The Company intends to continue meeting its reporting obligations under the Securities Exchange Act of 1934, as amended, and will provide updated disclosures through filings with the SEC and through OTC Markets Group, as applicable.
The Company is in the process of developing a new corporate website that will reflect its updated business direction and branding and expects to provide additional updates as they become available.
About Catalyst Crew Technologies Corp.
Catalyst Crew Technologies Corp. is an artificial intelligence-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The Company is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination.
Through technology development initiatives, strategic partnerships, and targeted acquisitions, CCTC is building an integrated healthcare technology platform positioned to address the growing demand for modernized healthcare delivery systems across emerging markets.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include, but are not limited to, statements regarding the Company’s business strategy, planned corporate name change, submission of the Company Related Action Notification Form to FINRA, anticipated ticker symbol change, regulatory review process, and future operations.
Forward-looking statements are based on current expectations and assumptions that involve risks and uncertainties. Actual results may differ materially from those expressed or implied due to various factors, including but not limited to FINRA’s review and processing of the Company Related Action Notification Form, the Company’s ability to obtain necessary approvals and financing, successful execution of its business plan, regulatory compliance requirements, and general market conditions.
The Company undertakes no obligation to update any forward-looking statements except as required by applicable law.
Disclaimer
This press release is provided for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company. This announcement relates solely to a change in corporate strategy and proposed corporate actions and does not represent the completion of commercial deployment or revenue-generating operations.
The Company is a development-stage enterprise and has not generated revenues from its newly announced business direction. There can be no assurance that the Company will successfully implement its business plan, complete acquisitions, secure financing, obtain regulatory approvals, or generate revenues.
Any investment decision should be made solely on the basis of information contained in the Company’s filings with the U.S. Securities and Exchange Commission and other publicly available documents. The Company’s securities involve a high degree of risk. Prospective investors are urged to carefully review all risk factors and disclosures contained in the Company’s SEC filings before making any investment decision.
No representation or warranty, express or implied, is made as to the accuracy or completeness of the information contained herein.
Investor Relations Contact
+1 (787) 476-2350
ir@catalystcrew.ai
View the original release on www.newmediawire.com
FAQ**
How does Catalyst Crew Technologies Corp. (CCTC) plan to leverage AI technologies within the Latin American healthcare market compared to other regions?
What specific challenges does Clean Coal Technologies Inc. CCTC anticipate facing during its transition to AI-enabled healthcare technology, especially in emerging markets?
In what ways does the strategic focus on telehealth and remote patient monitoring differentiate Clean Coal Technologies Inc. CCTC from competitors in the healthcare technology space?
What are the expected regulatory hurdles for Clean Coal Technologies Inc. CCTC as it navigates the corporate name and ticker symbol change with FINRA?
**MWN-AI FAQ is based on asking OpenAI questions about Clean Coal Technologies Inc (OTC: CCTC).
NASDAQ: CCTC
CCTC Trading
-30.67% G/L:
$0.52 Last:
28,970 Volume:
$0.75 Open:
